Results 51 to 60 of about 1,796 (140)

Impact of elexacaftor/tezacaftor/ivacaftor on gastrointestinal outcomes, inflammation, exocrine pancreatic function and fat malabsorption: Report of PROMISE pediatric substudy. [PDF]

J Cyst Fibros
Green N, Vu P, Xie J, Schwarzenberg SJ, Freedman S, Narkewicz M, Pittman J, Ratjen F, Rosenfeld M, Pope C, Duong J, Hoffman L, Heltshe S, Lusman SS, PROMISE Study Group.   +14 more
europepmc   +1 more source

Effect of Elexacaftor/Tezacaftor/Ivacaftor Treatment on Extrapulmonary Complications of Cystic Fibrosis. [PDF]

Adv Ther
Geiger JM, Brady BL, Lew CR, Jennings M, Mo C, Van Brunt K, Dezube R.   +6 more
europepmc   +1 more source

Piperine suppresses M1 phenotype and induces indoleamine 2,3-dioxygenase gene in LPS-stimulated murine macrophage cell line. [PDF]

BMC Res Notes
Gholijani N, Dehghan Z, Abolmaali SS, Talepoor AG, Kalantar K, Daryabor G.   +5 more
europepmc   +1 more source

Advances in the restoration of CFTR in children and pwCF with "mild disease". [PDF]

Pediatr Pulmonol
Cohen-Cymberknoh M.
europepmc   +1 more source

Functional Rescue of CFTR-Dependent Transport in a Pancreatic Ductal Epithelial Cell Model: The Impact of Pharmacological Modulation and Inflammation. [PDF]

Int J Mol Sci
Ludovico A, Battistini M, Baroni D.
europepmc   +1 more source

Screening of kinase inhibitors in the triple negative KRAS G13D-mutated MDA-MB-231 breast cancer cell line. [PDF]

Sci Rep
Stickler S, Eggerstorfer MT, Rieche M, Arslan S, Teufelsbauer M, Hohenegger M, Weigl L, Hamilton G.   +7 more
europepmc   +1 more source

Enantioselective radical chemistry: a bright future ahead. [PDF]

Beilstein J Org Chem
Renner AC, Thorat SS, Subramanian H, Sibi MP.   +3 more
europepmc   +1 more source

Home-based sleep monitoring using a novel non-contact, radar-based biomotion sensor in adults with cystic fibrosis treated with elexacaftor/tezacaftor/ivacaftor. [PDF]

Sleep Breath
Dietz-Terjung S, Straßburg S, Schöbel C, Schulte T, Dietz P, Gahbiche FE, Ortiz J, Taube C, Weinreich G, Sutharsan S, Welsner M.   +10 more
europepmc   +1 more source

Assessment of efficacy and tolerability of elexacaftor-tezacaftor-ivacaftor in an observational cohort study of "aged" people with cystic fibrosis. [PDF]

Ther Adv Respir Dis
Blankenship S, Flueckiger BV, Caleb G, Bailey J, Baker E, Garcia B, Krick S.   +6 more
europepmc   +1 more source

Impact of Elexacaftor-Tezacaftor-Ivacaftor on Gastrointestinal Symptoms, Intestinal Ultrasound, and Pancreatic Stiffness in Cystic Fibrosis. [PDF]

Clin Transl Gastroenterol
Fraquelli M, Piagnani A, Corti F, Lanfranchi C, Casazza G, Colombo C.   +5 more
europepmc   +1 more source